or Try an Advanced Search...

    Technical Analysis for STTK - Shattuck Labs, Inc.

    Grade Last Price % Change Price Change
    F 3.99 3.37% 0.13
    STTK closed up 3.37 percent on Monday, July 1, 2024, on 1.18 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Very Strong Down Down Down
    Historical STTK trend table...
    Date Alert Name Type % Chg
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Pocket Pivot Bullish Swing Setup 3.37%
    Volume Surge Other 3.37%
    Wide Bands Range Expansion 3.37%
    Oversold Stochastic Weakness 3.37%
    180 Bearish Setup Bearish Swing Setup 6.40%
    Slingshot Bearish Bearish Swing Setup 6.40%
    Wide Bands Range Expansion 6.40%
    Gapped Up Strength 6.40%
    Older End-of-Day Signals for STTK ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High about 9 hours ago
    10 DMA Resistance about 9 hours ago
    Down 5% about 9 hours ago
    Down 3% about 9 hours ago
    Up 5% about 9 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    STTK Chart by TradingView
    Basic chart:

    Profile

    Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian cancer. It also holds a collaboration agreement with Takeda Pharmaceuticals to develop SL-279252 that is in Phase 1 clinical trial in patients with advanced solid tumors and lymphoma. The company was founded in 2016 and is headquartered in Austin, Texas.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Cancer Life Sciences Solid Tumors Autoimmune Disease Treatment Of Cancer Lymphoma Clinical Research Clinical Trial Ovarian Cancer Advanced Solid Tumors Clinical Pharmacology Treatment Of Ovarian Cancer

    Is STTK a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 14 Shattuck (STTK) Announces Positive Interim Data on Cancer Drug
    Jun 14 Shattuck gains on early-stage data update for lead asset in blood cancer
    Jun 14 Shattuck Labs Announces Updated Positive Interim Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 in Combination with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid L...
    Jun 10 Shattuck gets FDA orphan drug designation for SL-172154 for AML
    Jun 10 Shattuck Labs Announces Orphan Drug Designation Granted by the U.S. Food and Drug Administration (FDA) for SL-172154 for the Treatment of Acute Myeloid Leukemia (AML)
    Jun 1 Most Shareholders Will Probably Agree With Shattuck Labs, Inc.'s (NASDAQ:STTK) CEO Compensation
    May 21 After Plunging -19.89% in 4 Weeks, Here's Why the Trend Might Reverse for Shattuck Labs (STTK)
    May 14 Shattuck Labs to Present Additional Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients at th...
    May 7 What Makes Shattuck Labs (STTK) a New Buy Stock
    May 7 Does Shattuck Labs (STTK) Have the Potential to Rally 34.17% as Wall Street Analysts Expect?
    See more STTK news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 11.76
    52 Week Low 1.3301
    Average Volume 494,003
    200-Day Moving Average 6.33
    50-Day Moving Average 7.73
    20-Day Moving Average 5.51
    10-Day Moving Average 4.10
    Average True Range 0.55
    RSI (14) 25.37
    ADX 56.44
    +DI 12.42
    -DI 36.54
    Chandelier Exit (Long, 3 ATRs) 5.92
    Chandelier Exit (Short, 3 ATRs) 4.99
    Upper Bollinger Bands 8.44
    Lower Bollinger Band 2.58
    Percent B (%b) 0.24
    BandWidth 106.23
    MACD Line -1.16
    MACD Signal Line -1.08
    MACD Histogram -0.0748
    Fundamentals Value
    Market Cap 188.08 Million
    Num Shares 47.1 Million
    EPS -2.24
    Price-to-Earnings (P/E) Ratio -1.78
    Price-to-Sales 323.03
    Price-to-Book 3.76
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 4.71
    Resistance 3 (R3) 4.68 4.41 4.59
    Resistance 2 (R2) 4.41 4.23 4.43 4.55
    Resistance 1 (R1) 4.20 4.11 4.31 4.23 4.51
    Pivot Point 3.93 3.93 3.98 3.95 3.93
    Support 1 (S1) 3.72 3.75 3.83 3.75 3.47
    Support 2 (S2) 3.45 3.63 3.47 3.43
    Support 3 (S3) 3.24 3.45 3.39
    Support 4 (S4) 3.27